Quest Partners LLC Has $34,000 Stock Position in Innospec Inc. (NASDAQ:IOSP)

Quest Partners LLC trimmed its position in Innospec Inc. (NASDAQ:IOSP - Free Report) by 97.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 304 shares of the specialty chemicals company's stock after selling 13,498 shares during the quarter. Quest Partners LLC's holdings in Innospec were worth $34,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in IOSP. Price T Rowe Associates Inc. MD grew its position in Innospec by 5.6% during the first quarter. Price T Rowe Associates Inc. MD now owns 17,228 shares of the specialty chemicals company's stock worth $2,222,000 after buying an additional 916 shares in the last quarter. DekaBank Deutsche Girozentrale acquired a new position in Innospec in the first quarter valued at about $66,000. CWM LLC lifted its position in Innospec by 239.6% during the second quarter. CWM LLC now owns 635 shares of the specialty chemicals company's stock worth $78,000 after purchasing an additional 448 shares during the period. Linden Thomas Advisory Services LLC grew its stake in Innospec by 2.0% during the second quarter. Linden Thomas Advisory Services LLC now owns 12,042 shares of the specialty chemicals company's stock worth $1,488,000 after buying an additional 235 shares in the last quarter. Finally, SG Americas Securities LLC increased its holdings in Innospec by 660.1% in the 2nd quarter. SG Americas Securities LLC now owns 9,767 shares of the specialty chemicals company's stock valued at $1,207,000 after buying an additional 8,482 shares during the period. Institutional investors own 96.64% of the company's stock.

Analyst Ratings Changes

Separately, StockNews.com cut shares of Innospec from a "strong-buy" rating to a "buy" rating in a research note on Thursday, August 8th.

Innospec Price Performance

NASDAQ:IOSP traded up $1.79 during trading hours on Monday, hitting $120.40. The company's stock had a trading volume of 80,751 shares, compared to its average volume of 109,381. Innospec Inc. has a twelve month low of $103.97 and a twelve month high of $133.71. The stock has a fifty day simple moving average of $114.50 and a 200-day simple moving average of $118.22. The company has a market capitalization of $3.00 billion, a P/E ratio of 20.83 and a beta of 1.08.

Innospec (NASDAQ:IOSP - Get Free Report) last announced its quarterly earnings results on Tuesday, November 5th. The specialty chemicals company reported $1.35 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.35. Innospec had a net margin of 7.68% and a return on equity of 13.33%. The company had revenue of $443.40 million for the quarter, compared to analyst estimates of $442.13 million. During the same period in the previous year, the firm posted $1.59 EPS. The firm's revenue was down 4.5% on a year-over-year basis. On average, equities analysts predict that Innospec Inc. will post 5.88 EPS for the current fiscal year.

Innospec Increases Dividend

The company also recently disclosed a Semi-Annual dividend, which was paid on Tuesday, November 26th. Investors of record on Monday, November 18th were given a dividend of $0.79 per share. The ex-dividend date was Monday, November 18th. This represents a yield of 1.3%. This is a positive change from Innospec's previous Semi-Annual dividend of $0.72. Innospec's payout ratio is currently 27.57%.

Insiders Place Their Bets

In other news, Director Milton C. Blackmore sold 1,035 shares of the firm's stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $122.92, for a total transaction of $127,222.20. Following the completion of the transaction, the director now owns 9,028 shares of the company's stock, valued at approximately $1,109,721.76. This trade represents a 10.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.52% of the company's stock.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.